Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis
Bioorganic Chemistry · 2024-07 · 148 · 107481
DOI: 10.1016/j.bioorg.2024.107481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-07. Verfasst von Seunghyun Ahn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, Dongduk Women's University, Seoul 02748, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Drug Design, Early Growth Response Protein 1. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Korea Drug Development Fund, Ministry of Trade, Industry and Energy, Ministry of Health and Welfare.
Abstract (Originalsprache)
Atopic dermatitis is a chronic inflammatory skin disease characterized by intense itching and frequent skin barrier dysfunctions. EGR-1 is a transcription factor that aggravates the pathogenesis of atopic dermatitis by promoting the production of various inflammatory cytokines. Three 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides (IT21, IT23, and IT25) were identified as novel inhibitors of EGR-1 DNA-binding activity. In silico docking experiments were performed to elucidate the binding conditions of the EGR-1 zinc-finger (ZnF) DNA-binding domain. Electrophoretic mobility shift assays confirmed the targeted binding effect on the EGR-1 ZnF DNA-binding domain, leading to dose-dependent dissociation of the EGR-1-DNA complex. At the functional cellular level, IT21, IT23, and IT25 effectively reduced mRNA expression of TNFα-induced EGR-1-regulated inflammatory genes, particularly in HaCaT keratinocytes inflamed by TNFα. In the in vivo efficacy study, IT21, IT23, and IT25 demonstrated the potential to alleviate atopic dermatitis-like skin lesions in the ear skin of BALB/c mice. These findings suggest that targeting the EGR-1 ZnF DNA-binding domain with 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamide derivatives (IT21, IT23, and IT25) could serve as lead compounds for the development of potential therapeutic agents against inflammatory skin disorders, including atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Chemistry, Dongduk Women's University, Seoul 02748, Republic of Korea.
- Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
- Division of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 05029, Republic of Korea.
- Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea; Cancer and Metabolism Institute, Konkuk University, Seoul 05029, Republic of Korea. Electronic address: shinsy@konkuk.ac.kr.
Förderung
- Korea Drug Development Fund
- Ministry of Trade, Industry and Energy
- Ministry of Health and Welfare
- Ministry of Science, ICT and Future Planning
- Konkuk University
- Kyungnam University
Zitieren
APA
Ahn, S., Yeo, H., Jung, E., Lee, Y., Koh, D., Lee, H., Han Lee, Y., Lim, Y., & Young Shin, S. (2024). Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis. Bioorganic Chemistry, 148, 107481. https://doi.org/10.1016/j.bioorg.2024.107481
Vancouver
Ahn S, Yeo H, Jung E, Lee Y, Koh D, Lee H, et al. Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis. Bioorganic Chemistry. 2024;148:107481. doi:10.1016/j.bioorg.2024.107481
BibTeX
@article{Ahn2024,
author = {Ahn, Seunghyun and Yeo, Hyunjin and Jung, Euitaek and Lee, Youngshim and Koh, Dongsoo and Lee, Hyeonhwa and Han Lee, Young and Lim, Yoongho and Young Shin, Soon},
title = {Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis},
journal = {Bioorganic Chemistry},
year = {2024},
volume = {148},
pages = {107481},
doi = {10.1016/j.bioorg.2024.107481}
}
EUVIMED